Overview

Study of ISA247 (Voclosporin) in De Novo Renal Transplantation

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
This study will see if voclosporin is safe and effective in preventing kidney transplant rejection.
Phase:
Phase 2
Details
Lead Sponsor:
Aurinia Pharmaceuticals Inc.
Treatments:
Cyclosporine
Tacrolimus